Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Health Policy Partnership is a private UK-based specialist health policy consultancy focused on driving health system and policy change rather than developing therapeutics. Founded in 2014, the firm works with clients and stakeholders across healthcare to produce evidence-based research, policy analysis, communications, and multistakeholder alliances intended to improve patient outcomes. Its work spans major disease and policy areas including oncology, cardiovascular disease, obesity, respiratory health, digital health, multimorbidity, and healthcare access. The company appears to operate as a services business with consulting, research, editorial, and communications capabilities, including support for initiatives such as the Heart Failure Policy Network and Lung Cancer Policy Network. It is healthcare-related, but it is not a biotech or drug-development company and does not appear to have a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Health Policy Partnership.